cancer
publication date
Innovation
Children's National Launches Innovation Partnership with Virginia Tech
New biomedical research facility will be developed on the health system's Research & Innovation campus; the collaboration is expected to...
Clinical Care
Second Malignancy Risk Sky-High for Childhood Cancer Survivors
Findings suggest need for heightened surveillance through adulthood.
Clinical Care
Do Cancer Care Providers Skip the 'Sex Talk' With Patients?
In small survey, oncologists and APPs didn't discuss potential impact of disease, treatment on sexuality.
Clinical Care
Many Cancer Patients Receive Questionable Intensive Treatments at End of Life
At the end of life, clinicians should engage their patients in conversations about care plans that include addressing the cost...
Clinical Care
Industry Dollars Reach Half of NCI Cancer Center Heads
One-quarter got general payments of 'significant financial interest.'
Finance
CMS Proposing Bundled Payment Model for Radiation Oncology
Participation would be mandatory for certain geographic areas during the model's projected five-year timeline.
Clinical Care
Cancer Urgent Care Clinics Slow Growth of ER Utilization
A cancer urgent care clinic in Texas reduced growth of emergency department utilization by more than half.
Strategy
City of Hope to Invest $1B in New Irvine Cancer Care Campus
The organization said it is accelerating its plans and upping its investment in Orange County, in response to the market's...
Clinical Care
Here's the SCOOP: New Oncology Pathway Program Boosts Patient Outcomes
A healthcare system is pioneering provision of palliative care and supportive services to oncology patients receiving curative treatment.
Clinical Care
Q&A With BS&W Oncology Leader on Cancer Costs and Research
An oncologist who pioneered immunotherapy cancer treatments at Johns Hopkins Medicine is now pursuing novel cancer care at Baylor Scott...
Clinical Care
More Bad News for MIS in Cervical Cancer
Significantly higher recurrence risk compared with abdominal hysterectomy.
Finance
CMS: Decision on CAR-T Therapy Coverage Delayed But 'Forthcoming'
The therapies have price tags as high as $425,000, which some say is a worthwhile investment.